Medical Devices Startups

CerebraAI builds AI software for emergency medicine, focused on stroke and brain-imaging analysis (including ASPECTS, ICH, and HEATMAP modules) used by hospitals and physicians in critical care. Its tools are used across 50+ hospitals in multiple countries, serving neurologists and emergency clinicians.

1 investor

Cerebriu develops machine learning software for medical imaging, applying AI to healthcare diagnostics. The company operates in the MedTech space with commercial activity across Europe and the US.

1 investor

Cerebro develops an AI-based clinical decision-support system for structured signal capture and pattern detection in brain and metabolic health, currently in experimental research phase for evaluation by clinical sites and research partners.

1 investor

Cerecura is a biotech company focused on developing RNA therapies to treat neurological disorders and neurodegeneration. The company leverages drug delivery expertise and neuroscience research to create next-generation treatments for patients with brain diseases.

1 investor

A medical device company developing EEG monitoring solutions designed for routine use in acute healthcare settings. The company combines academic research foundations with rigorous quality systems to deliver products for clinical monitoring applications.

1 investor

Ceretrieve Ltd. develops neurointerventional medical devices, including distal access catheters, thrombectomy devices, and related accessories, working with physicians to improve device performance and patient outcomes. It serves the interventional physician and neurovascular care market.

1 investor

Cerevanta provides AI-powered analysis of brain imaging to help neurologists make clinical decisions more effectively. The platform targets neurology care providers to reduce diagnostic delays and improve patient outcomes.

1 investor

CereVasc is developing the eShunt System, a minimally invasive device intended to treat communicating hydrocephalus in children and adults as an alternative to invasive neurosurgical procedures. The company operates in the medical device sector for neurological conditions.

1 investor

CereVu Medical develops an AI-driven wearable sensor that continuously monitors vital signs and detects biomarkers for pain and dyspnea, designed for use by healthcare providers and clinical settings.

1 investor

Cergentis is now part of Solvias and provides Targeted Locus Amplification (TLA) technology and genetic characterization services for advanced therapy development. The company serves pharmaceutical and biotech innovators with CMC analytical testing from drug development through commercialization.

1 investor

Certa Therapeutics develops targeted therapeutics to treat fibrotic diseases including scleroderma, chronic kidney disease, diabetic nephropathy, and focal segmental glomerulosclerosis. The company serves patients with serious, often life-threatening fibrotic conditions.

1 investor

Certified Laboratories operates a network of 30+ ISO 17025-accredited testing labs across North America, providing microbiology, analytical chemistry, contract research, and certification & audit services. It serves the food & beverage industry as well as cosmetics, personal care, over-the-counter drug, dietary supplement, and botanical companies with safety and quality testing.

1 investor

Ceryx Medical develops medical device technology, presenting a leadership and research team alongside its publications. The page provides limited detail on the specific product beyond the company's medical technology focus.

1 investor

Cumberland Emerging Technologies provides development partnerships with researchers and companies to advance early-stage biomedical technologies toward commercialization, and operates a life sciences incubator facility in Nashville offering laboratory space and support services to pharmaceutical, medical device, and diagnostics firms.

1 investor

Cetis Flex manufactures flexible packaging, labels, and commercial printing solutions for beverage, food, pharmaceutical, and cosmetic industries. The company produces a range of branded products including patient alert cards, sleeves, wraparound labels, pouches, films, and brand protection solutions.

1 investor

CGenetix develops liquid biopsy biomarkers using circulating cell-free DNA to detect organ damage, with a focus on transplantation (kidney, lung, pancreas) rejection diagnostics. The company applies techniques such as digital PCR, NGS and bioinformatics to build in vitro diagnostic tests for the medical and clinical community.

1 investor

CHA Biotech is a South Korean biotechnology company operating in areas including cord blood banking, cell insurance, genomics, CDMO manufacturing, and healthcare consulting. It also runs related businesses such as the Chaum health center and IT services.

1 investor

Channel Medsystems (Cerene) develops easy-to-use medical devices for women's health, aimed at women and their gynecologists. The company operates in the gynecological medical device and femtech category.

1 investor

CheckCorp manufactures precision-engineered heating and ventilation systems for vehicle seats, cushions, and commercial equipment surfaces. The company offers turn-key solutions including temperature controls, heat and massage features, and safety protections, serving automotive and equipment manufacturers.

1 investor

Cheelcare designs and manufactures medical mobility devices for wheelchair users, including the Companion power assist for manual wheelchairs, the Curio power wheelchair with a robotic base, and the AWARE rear-view camera system. The company handles product development through commercialization from its facility in Markham, Ontario, Canada.

1 investor

ChemoPharma is a solutions platform in Malaysia providing clinical diagnostics, analytical and industrial solutions for oil and gas, and life sciences offerings. The company also delivers laboratory information management systems, project management, and technical support services across the diagnostic and scientific technology value chain.

1 investor

ChezLeon makes DP-Tx, a patented textile bra insert that uses differential pressure to gently massage tissue and keep lymphatic fluid moving, treating lymphoedema, mastitis, and post-breast-surgery swelling. The product is aimed at patients and healthcare professionals in cancer and breast care, and is listed on the Australian Register of Therapeutic Goods as a Class 1 Medical Device.

1 investor

Chiesi is a global pharmaceutical company that develops and distributes medications across multiple therapeutic areas. The company operates through subsidiaries in Europe, Asia, the Americas, and other regions.

1 investor

Choir AI provides AI agents that help pharmaceutical and medical device companies automate commercial operations, medical affairs, finance, forecasting, sales, regulatory access, and global market functions.

1 investor